European Journal of Echocardiography Advance Access originally published online on June 13, 2008
European Journal of Echocardiography 2008 9(6):819-821; doi:10.1093/ejechocard/jen180
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Fatal pheochromocytoma crisis precipitated by dobutamine stress echocardiography
1 Department of Cardiology, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199, USA
2 Department of Pathology, Baystate Medical Center, 759 Chestnut Street, Springfield, MA 01199, USA
Received 7 April 2008; accepted after revision 18 May 2008; online publish-ahead-of-print 13 June 2008.
* Corresponding author. Tel: +1 4137948722; fax: +1 4137940198. E-mail address: mdheart{at}gmail.com
| Abstract |
|---|
The safety of dobutamine stress echocardiography (DSE) has been demonstrated in multiple studies with a major complication rate of <1%. Specifically, ventricular tachycardia during DSE has a reported incidence of 0.3%, and has been bound to be of no prognostic significance in patients without obstructive coronary artery disease. We report a unique case of fatal pheochromocytoma crisis precipitated by DSE in a patient with heretofore unknown adrenal disease. We are once again reminded that no diagnostic modality is absolutely without risk; however, minimal they might be.
Keywords: Dobutamine echocardiography; Stress echocardiography; Stress testing; Pheochromocytoma crisis; Ventricular tachycardia